Biolife Solutions

BLFSNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$1.818 B

$37.18 +1.34%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$4.59M

Loss-making

Shares outstanding

48,906,704

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 28 →

#4TransMedics GroupTMDX$3.03B
#5AxogenAXGN$2.69B
#6Biolife SolutionsBLFS$1.82B
#7CONMEDCNMD$1.34B
#8CeribellCBLL$930.7M

What if Biolife Solutions were worth as much as…

Open the what-if tool →

Gold $30.3T

$619,016.45

Per share 16,649× higher

Bitcoin $1.72T

$35,164.99

Per share 946× higher

Nvidia $5.48T

$112,047.17

Per share 3,014× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Biolife Solutions are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.